Keyphrases
Bone Morphogenetic protein-2 (BMP-2)
100%
Autograft
100%
Lumbar Fusion
100%
Fusion Outcomes
100%
Confidence Interval
50%
Seroma
50%
Radiculitis
50%
Odds Ratio
37%
Complication Rate
25%
Associated Complications
25%
Off-label Use
25%
Surgical Complications
25%
Fusion Rate
25%
Fusion Process
25%
Retrospective Cohort Study
12%
Patient Data
12%
Clinical Outcomes
12%
Diabetes
12%
Computed Tomography
12%
Medical Records
12%
Significant Predictors
12%
Bone Morphogenetic Protein
12%
Follow-up Time
12%
Logistic Regression Model
12%
Deep Infection
12%
Pseudarthrosis
12%
Radiographic Outcomes
12%
Operation Notes
12%
Imaging Studies
12%
Smokers
12%
Plain X-ray
12%
Evidence Support
12%
Overall Complications
12%
Patient Samples
12%
Clinical Follow-up
12%
Anterior-posterior
12%
Osteolysis
12%
Spine Surgery
12%
X-ray Computed Tomography (X-CT)
12%
To Determine the Effectiveness
12%
Lumbar Degenerative Disease
12%
Bone Fusion
12%
Degenerative Spine Disease
12%
Instrumented Spinal Fusion
12%
Clinic Notes
12%
Complex Spine Surgery
12%
Ectopic Bone
12%
Follow-up Clinic
12%
Medicine and Dentistry
Autograft
100%
Recombinant Bone Morphogenetic Protein 2
100%
Posterior Lumbar Interbody Fusion
100%
Seroma
50%
Radiculitis
50%
Odds Ratio
37%
Spine Surgery
25%
Postoperative Complication
25%
Off-Label Use
25%
Patient-Data
12%
Malignant Neoplasm
12%
Infection
12%
Diabetes
12%
Retrospective Cohort Study
12%
Smoking
12%
Computer Assisted Tomography
12%
Logistic Regression Analysis
12%
Retrospective Study
12%
Osteolysis
12%
Pseudarthrosis
12%
Bone Morphogenetic Protein
12%
Guanine Nucleotide Binding Protein
12%
Spinal Fusion
12%
Spine Disease
12%
X-Ray Tomography
12%
Pharmacology, Toxicology and Pharmaceutical Science
Recombinant Bone Morphogenetic Protein 2
100%
Seroma
66%
Radiculitis
66%
Postoperative Complication
33%
Off-Label Use
33%
Infection
16%
Cohort Study
16%
Malignant Neoplasm
16%
Bone Morphogenetic Protein
16%
Guanine Nucleotide Binding Protein
16%
Retrospective Study
16%
Spine Disease
16%
Pseudarthrosis
16%